Back to User profile » Dr Tina Bhutani
Papers published by Dr Tina Bhutani:
Exploring the Quality-of-Life Impact, Disease Burden, and Management Challenges of GPP: The Provider and Patient Perspective [Podcast]
Hawkes JE, Reisner DV, Bhutani T
Clinical, Cosmetic and Investigational Dermatology 2023, 16:3333-3339
Published Date: 17 November 2023
Management of Plaque Psoriasis in Adults: Clinical Utility of Tapinarof Cream
Spencer RK, Jin JQ, Elhage KG, Davis MS, Liao W, Bhutani T
Psoriasis: Targets and Therapy 2023, 13:59-69
Published Date: 25 October 2023
Exploring the Clinical Features, Immunopathogenesis and Approach to Diagnosis for Generalized Pustular Psoriasis [Podcast]
Bhutani T, Hawkes JE
Clinical, Cosmetic and Investigational Dermatology 2023, 16:1553-1558
Published Date: 16 June 2023
Clinical Utility of Deucravacitinib for the Management of Moderate to Severe Plaque Psoriasis
Jin JQ, Spencer RK, Reddy V, Bhutani T, Liao W
Therapeutics and Clinical Risk Management 2023, 19:413-423
Published Date: 18 May 2023
Psoriasis and Exercise: A Review
Yeroushalmi S, Hakimi M, Chung M, Bartholomew E, Bhutani T, Liao W
Psoriasis: Targets and Therapy 2022, 12:189-197
Published Date: 2 July 2022
Dietary Intervention and Supplements in the Management of Psoriasis: Current Perspectives
Chung M, Bartholomew E, Yeroushalmi S, Hakimi M, Bhutani T, Liao W
Psoriasis: Targets and Therapy 2022, 12:151-176
Published Date: 22 June 2022
The Role of IL-17 Cytokines in Psoriasis
Mosca M, Hong J, Hadeler E, Hakimi M, Liao W, Bhutani T
ImmunoTargets and Therapy 2021, 10:409-418
Published Date: 24 November 2021
Biologic Treatments of Psoriasis: An Update for the Clinician
Brownstone ND, Hong J, Mosca M, Hadeler E, Liao W, Bhutani T, Koo J
Biologics: Targets and Therapy 2021, 15:39-51
Published Date: 16 February 2021
Impact of Halobetasol Propionate and Tazarotene Lotion 0.01%/0.045% in the Management of Plaque Psoriasis in Adults
Reddy V, Myers B, Yang EJ, Bhutani T
Clinical, Cosmetic and Investigational Dermatology 2020, 13:391-398
Published Date: 11 June 2020
Acrodermatitis continua of Hallopeau: clinical perspectives
Smith MP, Ly K, Thibodeaux Q, Bhutani T, Liao W, Beck KM
Psoriasis: Targets and Therapy 2019, 9:65-72
Published Date: 9 August 2019
Home phototherapy for patients with vitiligo: challenges and solutions
Smith MP, Ly K, Thibodeaux Q, Bhutani T, Nakamura M
Clinical, Cosmetic and Investigational Dermatology 2019, 12:451-459
Published Date: 28 June 2019
Diagnosis and screening of patients with generalized pustular psoriasis
Ly K, Beck KM, Smith MP, Thibodeaux Q, Bhutani T
Psoriasis: Targets and Therapy 2019, 9:37-42
Published Date: 20 June 2019
Evaluating guselkumab: an anti-IL-23 antibody for the treatment of plaque psoriasis
Yang EJ, Smith MP, Ly K, Bhutani T
Drug Design, Development and Therapy 2019, 13:1993-2000
Published Date: 18 June 2019
Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
Sekhon S, Jeon C, Nakamura M, Yan D, Afifi L, Bhutani T, Levin E
Psoriasis: Targets and Therapy 2017, 7:65-72
Published Date: 16 November 2017
Excimer laser for the treatment of psoriasis: safety, efficacy, and patient acceptability
Abrouk M, Levin E, Brodsky M, Gandy JR, Nakamura M, Zhu TH, Farahnik B, Koo J, Bhutani T
Psoriasis: Targets and Therapy 2016, 6:165-173
Published Date: 12 December 2016
Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability
Farahnik B, Patel V, Beroukhim K, Zhu TH, Abrouk M, Nakamura M, Singh R, Lee K, Bhutani T, Koo J
Psoriasis: Targets and Therapy 2016, 6:105-111
Published Date: 28 July 2016